NAD plus COVID research: what we know about NAD+ depletion, immune support, and supplements like NR and NMN for readers in the United States.
No NAD+ supplement is approved to prevent or treat COVID-19. Early laboratory research suggests that SARS-CoV-2 infection can disrupt NAD+ metabolism, and scientists have studied NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) for immune support, but human clinical evidence remains limited. This article explains what is known, what is uncertain, and how to think about NAD+ products if you are concerned about COVID-19.
What Is NAD+ and Why Does It Matter for COVID-19?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It helps convert food into energy, repairs DNA, and regulates inflammation through proteins called sirtuins and PARPs. Without adequate NAD+, cells cannot produce energy efficiently or respond to stress properly.
COVID-19 can trigger intense inflammation and oxidative stress. Some researchers hypothesize that this process depletes NAD+, which might slow cellular recovery and worsen symptoms. That hypothesis is plausible but not proven.
While nad plus food sources like milk, fish, and whole grains provide small amounts of related compounds, diet alone does not dramatically raise NAD+ levels. Most supplements use precursors that the body converts into NAD+.
How COVID-19 May Affect NAD+ Levels
Several studies have found that SARS-CoV-2 activates PARP enzymes, which consume NAD+ as part of the DNA damage response. In severe COVID-19, this could contribute to an energy crisis in immune cells.
A 2020 review proposed that NAD+ depletion might link COVID-19 severity to age-related decline in NAD+ levels. Older adults and people with metabolic conditions tend to have lower baseline NAD+. That overlap is interesting, but it does not prove that boosting NAD+ changes outcomes.
Researchers have also observed that inflammation itself can reduce NAD+ availability. In theory, a cycle could form: infection causes inflammation, inflammation lowers NAD+, and low NAD+ impairs recovery. So far, this remains a laboratory and theoretical model, not a clinically validated treatment target.
Does NAD+ Boost the Immune System?
NAD+ supports the function of immune cells such as macrophages and T cells. In animal studies, raising NAD+ levels has improved some markers of immune function and reduced inflammation.
However, a stronger immune response is not always better. Severe COVID-19 is sometimes driven by an overactive immune response, not a weak one. Scientists do not yet know whether NAD+ supplementation would calm or intensify that response in infected people.
What Clinical Research Says About NAD+ Supplements and COVID-19
As of today, no randomized controlled trial has shown that any NAD+ supplement prevents, treats, or cures COVID-19. The FDA has not approved NR, NMN, or direct NAD+ products for COVID-19.
Some small human trials have tested NR for other conditions, such as heart failure and metabolic syndrome, with mixed results. For COVID-19 specifically, most evidence comes from cell cultures and animal models.
If you are wondering is nad plus safe during or after a COVID infection, the honest answer is that long-term safety data in that specific context are lacking. Mild side effects like nausea or flushing have been reported in some users, but serious risks are rare at typical oral doses.
Comparing NAD+ Supplement Forms and Precursors
NAD+ is not well absorbed when taken orally, so most products use precursors or alternative delivery methods. The table below compares common options.
| Form | What it is | COVID-19 evidence | Typical studied dose | FDA status |
|---|---|---|---|---|
| Nicotinamide riboside (NR) | Oral precursor | No human COVID-19 trials; cell studies only | 300–600 mg/day | Sold as a supplement; not FDA-approved for COVID-19 |
| Nicotinamide mononucleotide (NMN) | Oral precursor | No human COVID-19 data | 250–500 mg/day | Not FDA-approved; regulatory status varies |
| NAD+ IV infusion | Intravenous | No COVID-19 trials | 100–1000 mg | Not FDA-approved for COVID-19 |
| NAD+ nasal spray | Intranasal | No evidence | Variable | Not FDA-approved |
| NAD+ jelly | Oral gel | No evidence | Variable | Not FDA-approved |
nad plus nr is one of the most researched precursor forms. If you are deciding which is better nmn or nad plus for general wellness, note that no head-to-head trials have compared them for COVID-19 or any infectious disease.
NAD+ jelly and nasal sprays are newer delivery formats that may appeal to people who dislike capsules. Some international vendors sell NAD+ capsules, and branded products follow the same basic category. None of these formats has been proven superior for COVID-19.
Safety, Side Effects, and Practical Considerations
Oral NAD+ precursors are generally well tolerated in studied doses. Reported side effects include nausea, headache, fatigue, and mild flushing.
People who are pregnant, breastfeeding, immunocompromised, or taking medications should talk to a healthcare professional before using any NAD+ supplement. High-dose IV NAD+ can cause serious reactions and should only be given under medical supervision.
Choosing the right nad plus for you should start with a conversation with your doctor, not a marketing claim. No supplement replaces proven COVID-19 prevention and treatment strategies, including vaccination and approved antiviral medications.
Bottom Line on NAD Plus and COVID
NAD+ is essential for cellular function, and COVID-19 may disturb NAD+ metabolism. However, no clinical trial has shown that NAD+ supplements prevent or treat COVID-19.
If you want to support your immune system, focus on sleep, nutrition, exercise, and vaccination. Discuss any supplement, including NR or NMN, with your healthcare provider.
Frequently Asked Questions
Can NAD+ supplements prevent COVID-19?
No. There is no clinical evidence that NAD+ supplements prevent SARS-CoV-2 infection. Vaccination, masking, and hygiene remain the proven prevention strategies.
Does NAD+ help with long COVID?
Some researchers are studying NAD+ depletion in long COVID, but no published randomized controlled trial shows that NAD+ supplements improve long COVID symptoms. Anyone with lingering symptoms should see a healthcare provider.
What is the best NAD+ supplement for immune support?
There is no single best NAD+ supplement for immune support because human data are limited. NR and NMN are the most studied oral precursors, and doses typically range from 250 to 600 mg per day. Talk to your doctor before starting any supplement, especially if you have a medical condition or take medication.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.